omalizumab - Robuta Search

https://adisinsight.springer.com/drugsafety/803927957?error=cookies_not_supported&code=ee868b54-436d-4560-a7ac-5793a7b69cfd Omalizumab - AdisInsight A patient [age not stated; sex not stated] with asthma experienced limb numbness, eosinophilia, mononeuritis multiplex and eosinophilic granulomatous omalizumab adisinsight https://adisinsight.springer.com/drugsafety/803430127?error=cookies_not_supported&code=4bb66d68-6c29-4f6c-82c0-a2458c314536 Omalizumab - AdisInsight In a study of 29 patients, one patient [age and sex not stated] was described, who developed angioedema following treatment with omalizumab for symptomatic omalizumab adisinsight https://adisinsight.springer.com/trials/700392646?error=cookies_not_supported&code=60ff774e-2a67-45f8-b3b3-08baabdcdb23 Omalizumab for monotherapy treatment of patients with food allergies to plant-based foods due to... To analyse the clinical efficacy of treatment with omalizumab as monotherapy for 16 weeks in patients allergic to vegetables due to sensitisation to LTP and https://eprints.ncl.ac.uk/184080 The oral corticosteroid-sparing effect of omalizumab in children with severe asthma - ePrints -... https://experts.arizona.edu/en/publications/comparative-effectiveness-of-dupilumab-and-omalizumab-on-asthma-e/ Comparative effectiveness of dupilumab and omalizumab on asthma exacerbations and systemic... comparative effectiveness dupilumab omalizumab asthma exacerbations https://pubmed.ncbi.nlm.nih.gov/33434384/ Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal... Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review efficacy and safety conventional treatment clinical https://pubmed.ncbi.nlm.nih.gov/41555682/ Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food Allergy: OSAFA... The findings of this study indicate that the efficacy of Omalizumab is independent, all else being equal, from total IgE levels, suggesting that body weight is... https://adisinsight.springer.com/drugsafety/803664089?error=cookies_not_supported&code=314d8dee-bec5-48b0-905e-19272e25c0df Formoterol/fluticasone-propionate/omalizumab - AdisInsight A 68-year-old man developed Cryptococcosis in the vocal cords, trachea, and bronchi following treatment with omalizumab and formoterol/fluticasone-propionate fluticasone propionate formoterol omalizumab adisinsight https://www.xolairhcp.com/ Allergic Asthma, CSU, CRSwNP & Food Allergy | XOLAIR® (omalizumab) Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and... allergic asthma food allergy csu omalizumab https://su.diva-portal.org/smash/record.jsf?pid=diva2:1518773 A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral... https://www.nice.org.uk/search?q=Omalizumab Omalizumab | Search results | NICE search results omalizumab nice https://pubmed.ncbi.nlm.nih.gov/31275903/ Successful Treatment With Omalizumab in a Child With Asthma and Urticaria: A Clinical Case Report Childhood urticaria is not rare, although its persistence is less frequent. In children, chronic spontaneous urticaria (CSU) is associated with comorbidities,... https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/omalizumab-marketed-xolair-information Omalizumab (marketed as Xolair) Information | FDA Omalizumab (marketed as Xolair) Information omalizumab marketed xolair information fda https://pubmed.ncbi.nlm.nih.gov/30684255/ Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe... Omalizumab was shown to be an effective add-on therapy for patients with persistent severe asthma and allowed reducing key drivers of asthma-related costs. https://adisinsight.springer.com/drugsafety/803550562?error=cookies_not_supported&code=1b072f69-4b09-4a3b-b036-c082e6d60159 Benralizumab/dupilumab/omalizumab - AdisInsight In a retrospective observational study involving 270 patients treated with biological therapy between May 2015 and December 2019 at Cleveland Clinic Abu Dhabi, benralizumab dupilumab omalizumab adisinsight https://pubmed.ncbi.nlm.nih.gov/34530020/ Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study The efficacy and safety profile from this study supports extended omalizumab treatment up to 1 year for CRSwNP with inadequate response to nasal... https://hspop.uw.edu/publication/an-evaluation-of-the-cost-effectiveness-of-omalizumab-for-the-treatment-of-severe-allergic-asthma/ An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.... Sullivan SD, Turk F. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy. 2008 Jun;63(6):670-84. doi:... of the cost effectiveness https://www.xolair.com/ XOLAIR® (omalizumab) | Allergic Asthma, CSU, CRSwNP & Food Allergy Treatment Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and food... allergic asthma food allergy omalizumab csu treatment https://pubmed.ncbi.nlm.nih.gov/29901580/ Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case... The satisfactory response to omalizumab after the failure of all previous traditional treatments, confirms the efficacy of this biological drug in the therapy... https://pmc.ncbi.nlm.nih.gov/articles/PMC6790683/ The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma... Mepolizumab and omalizumab are treatments for distinct but overlapping severe asthma phenotypes. To assess if patients eligible for both biologics but not... https://adisinsight.springer.com/drugsafety/803928884?error=cookies_not_supported&code=2454bd97-fecd-462e-a8be-a94eea9602a0 Omalizumab - AdisInsight A report described chronic spontaneous urticaria that remained refractory despite prior omalizumab treatment [dose, route and duration not stated] due to omalizumab adisinsight https://pubmed.ncbi.nlm.nih.gov/27142072/ Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real... The results of this study confirm the effectiveness of the addition of omalizumab to standard therapy in patients with uncontrolled severe persistent asthma.